Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults
Author(s) -
Kailey Hughes,
Donald B. Middleton,
Mary Patricia Nowalk,
G.K. Balasubramani,
Emily T. Martin,
Manjusha Gaglani,
H. Keipp Talbot,
Manish M. Patel,
Jill M. Ferdinands,
Richard K. Zimmerman,
Fernanda P. Silveira,
Heather Eng,
Theresa M. Sax,
Sean Saul,
Charles R. Rinaldo,
Lori Steiffel,
John Williams,
Monika Johnson,
Kempapura Murthy,
Tresa McNeal,
Shekar Ghamande,
Victor Escobedo,
Anne Robertson,
Lydia Clipper,
Arundhati Rao,
Kevin Chang,
Marcus Volz,
Kimberly Walker,
Alejandro C. Arroliga,
Arnold S. Monto,
Ryan E. Malosh,
Joshua G. Petrie,
Adam S. Lauring,
Caroline Cheng,
Hannah E. Segaloff,
Erin McSpadden,
Emileigh Johnson,
Rachel Truscon,
Lois Lamerato,
Susan Davis,
Marcus Zervos,
Dayna Wyatt,
Yuwei Zhu,
Zhouwen Liu,
Rendie McHenry,
Natasha Halasa,
Sandra Alvarez Calvillo,
Stephanie Longmire,
Laura S Stewart,
Alicia M. Fry,
Elif Alyanak,
Emily Smith,
Courtney Strickland,
Sarah Spencer,
Brendan Flannery,
Jessie R. Chung,
Xiyan Xu,
Stephen Lindstrom,
LaShondra Berman,
Wendy Sessions,
Rebecca Kondor
Publication year - 2020
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciaa1927
Subject(s) - medicine , influenza vaccine , virology , orthomyxoviridae , intensive care medicine , immunology , influenza a virus , vaccination , virus
Yearly influenza immunization is recommended for immunocompromised (IC) individuals, although immune responses are lower than that for the nonimmunocompromised and the data on vaccine effectiveness (VE) in the IC is scarce. We evaluated VE against influenza-associated hospitalization among IC adults.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom